RxDoctor Payments Data

Lilla Berck, MD

Internal Medicine · Bloomington, ILNPI 1396946125

Payments from drug & device makers

$2,105in general payments, 2019–2025

Across 124 payments — averaging $16.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$610
  • Pfizer$337
  • Johnson & Johnson$253
  • GSK$171
  • Abbott$132
  • Inspire Medical Systems, Inc.$105
  • plus $497 from 18 others

What the payments were for

  • Food & beverage$2,100100%
  • Education$50%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,105 in reported general payments places this provider in the 85th percentile of 5,182 internal medicine providers in Illinois.

See all internal medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$244,318
Medicare patients
337
Services billed
5,765

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide104$146,008
EliquisApixaban106$138,663
JardianceEmpagliflozin78$103,940
MounjaroTirzepatide87$99,743
TrulicityDulaglutide49$78,709
XareltoRivaroxaban30$43,007
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog32$32,308
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog19$23,673
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog16$19,310
Incruse ElliptaUmeclidinium Bromide18$12,395
Spiriva RespimatTiotropium Bromide11$12,261
Aimovig AutoinjectorErenumab-Aooe12$8,962
TrulancePlecanatide13$8,311
Lantus SolostarInsulin Glargine,hum.Rec.Anlog44$6,551
Breo ElliptaFluticasone/Vilanterol12$6,227

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$16$178,452136 claims
Novo NordiskOzempic$85$146,008104 claims
PfizerEliquis$337$138,663106 claims
Boehringer IngelheimJardiance, Spiriva Respimat$29$116,20189 claims
Johnson & JohnsonXarelto$253$43,00730 claims
GSKIncruse Ellipta, Breo Ellipta$171$18,62330 claims
AbbVieSynthroid$610$2,34947 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 5,182 internal medicine providers in Illinois.

Other internal medicine in Bloomington

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →